+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Idiopathic Hypersomnia (IH): Market View - Product Thumbnail Image

Idiopathic Hypersomnia (IH): Market View

  • Report
  • April 2025
  • 77 Pages
  • Global
From
Phenylketonuria (PKU): Market View - Product Thumbnail Image

Phenylketonuria (PKU): Market View

  • Report
  • March 2025
  • 72 Pages
  • Global
From
From
Erythrodermic Psoriasis - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Erythrodermic Psoriasis - Global Clinical Trials Review, 2025

  • Clinical Trials
  • March 2025
  • 52 Pages
  • Global
From
Pulmonary Fibrosis - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Pulmonary Fibrosis - Global Clinical Trials Review, 2025

  • Clinical Trials
  • March 2025
  • 624 Pages
  • Global
From
From
From
Alopecia Areata: Opportunity Assessment and Forecast to 2033 - Product Thumbnail Image

Alopecia Areata: Opportunity Assessment and Forecast to 2033

  • Report
  • March 2025
  • 81 Pages
  • Global
From
Diffuse Cutaneous Systemic Sclerosis - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Diffuse Cutaneous Systemic Sclerosis - Global Clinical Trials Review, 2025

  • Clinical Trials
  • February 2025
  • 107 Pages
  • Global
From
Severe Asthma: Eight-Market Drug Forecast and Market Analysis - Product Thumbnail Image

Severe Asthma: Eight-Market Drug Forecast and Market Analysis

  • Report
  • February 2025
  • 135 Pages
  • Global
From
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more